Antigen loss variants (ALVs) refer to cancer cells that have undergone genetic or epigenetic changes resulting in the loss or alteration of specific antigens. These antigens are typically proteins or molecules expressed on the surface of cancer cells that can be recognized by the immune system or targeted by therapeutic agents. The loss of these antigens can help cancer cells evade immune detection and therapy.
